Suppr超能文献

相似文献

1
Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2011 Feb 1;183(3):330-40. doi: 10.1164/rccm.201002-0154OC. Epub 2010 Sep 2.
3
Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.
Am J Pathol. 2009 Mar;174(3):782-96. doi: 10.2353/ajpath.2009.080345.
4
Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice.
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):154-163. doi: 10.1161/ATVBAHA.117.310207. Epub 2017 Nov 30.
5
Cigarette Smoke Directly Promotes Pulmonary Arterial Remodeling and Kv7.4 Channel Dysfunction.
Am J Respir Crit Care Med. 2021 May 15;203(10):1290-1305. doi: 10.1164/rccm.201911-2238OC.
6
Neprilysin regulates pulmonary artery smooth muscle cell phenotype through a platelet-derived growth factor receptor-dependent mechanism.
Hypertension. 2013 Apr;61(4):921-30. doi: 10.1161/HYPERTENSIONAHA.111.199588. Epub 2013 Feb 4.
7
Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
J Heart Lung Transplant. 2024 Jul;43(7):1090-1101. doi: 10.1016/j.healun.2024.02.1044. Epub 2024 Feb 19.
8
Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig.
Respir Res. 2009 Aug 14;10(1):76. doi: 10.1186/1465-9921-10-76.
10
Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
Am J Respir Crit Care Med. 2008 Sep 15;178(6):592-604. doi: 10.1164/rccm.200803-380OC. Epub 2008 Jun 12.

引用本文的文献

1
Advancements in preclinical human-relevant modeling of pulmonary vasculature on-chip.
Eur J Pharm Sci. 2024 Apr 1;195:106709. doi: 10.1016/j.ejps.2024.106709. Epub 2024 Jan 19.
3
Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19).
Biomed Pharmacother. 2022 Apr;148:112718. doi: 10.1016/j.biopha.2022.112718. Epub 2022 Feb 14.
4
Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives.
Naunyn Schmiedebergs Arch Pharmacol. 2022 Mar;395(3):275-283. doi: 10.1007/s00210-022-02206-6. Epub 2022 Jan 28.
5
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.
Front Cardiovasc Med. 2021 Apr 12;8:649512. doi: 10.3389/fcvm.2021.649512. eCollection 2021.
7
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19.
Eur J Pharmacol. 2020 Dec 15;889:173615. doi: 10.1016/j.ejphar.2020.173615. Epub 2020 Oct 1.
8
Neprilysin expression and functions in development, ageing and disease.
Mech Ageing Dev. 2020 Dec;192:111363. doi: 10.1016/j.mad.2020.111363. Epub 2020 Sep 26.
10
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.
Biochem Pharmacol. 2020 Aug;178:114057. doi: 10.1016/j.bcp.2020.114057. Epub 2020 May 27.

本文引用的文献

1
Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension.
Adv Exp Med Biol. 2010;661:251-64. doi: 10.1007/978-1-60761-500-2_16.
2
Is methylation the key to CD10 loss?
J Pediatr Hematol Oncol. 2010 Jan;32(1):2-3. doi: 10.1097/MPH.0b013e3181c74aca.
3
Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema.
Am J Respir Crit Care Med. 2010 Feb 1;181(3):218-25. doi: 10.1164/rccm.200908-1189OC. Epub 2009 Oct 29.
4
Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity.
Am J Respir Crit Care Med. 2009 Dec 15;180(12):1196-207. doi: 10.1164/rccm.200903-0324OC. Epub 2009 Oct 1.
6
Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
Semin Respir Crit Care Med. 2009 Aug;30(4):458-70. doi: 10.1055/s-0029-1233315. Epub 2009 Jul 24.
8
Detection of 4-hydroxy-2-nonenal- and 3-nitrotyrosine-modified proteins using a proteomics approach.
Methods Mol Biol. 2009;519:351-61. doi: 10.1007/978-1-59745-281-6_22.
9
Role for interleukin-6 in COPD-related pulmonary hypertension.
Chest. 2009 Sep;136(3):678-687. doi: 10.1378/chest.08-2420. Epub 2009 Apr 6.
10
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.
Am J Respir Crit Care Med. 2009 Jun 1;179(11):1048-54. doi: 10.1164/rccm.200811-1678OC. Epub 2009 Feb 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验